Skip to main content
SpringerLink
Log in
Book cover

Chronic Headache pp 335–344Cite as

Neurostimulation in the Management of Chronic Migraine

  • Chapter
  • First Online:

  • 1262 Accesses

Abstract

Chronic migraine is both a prevalent and disabling neurologic disorder with significant impact on the health-related quality of life and economic well-being of those suffering from the condition. In tertiary headache centers, the use of both pharmacological and non-pharmacological interventions is commonplace. Available pharmacologic treatments with established efficacy in multiple randomized controlled trials are few and include oral topiramate and intramuscular onabotulinumtoxinA injections per the protocol put forth by the PREEMPT studies. Patient preference, treatment response, and treatment tolerability sometimes shift the focus of management to non-pharmacologic strategies. Among these is the emerging field of neurostimulation in the management of migraine. The aim of this chapter is to review the current body of knowledge of neurostimulation techniques including occipital nerve stimulation, transcutaneous supraorbital nerve stimulation, single-pulse transcranial magnetic stimulation, repetitive-pulse transcranial magnetic stimulation, transcranial direct current stimulation, vagus nerve stimulation, and sphenopalatine ganglion stimulation as it pertains to the management of migraine.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50(6):921–36.

    Article  PubMed  Google Scholar 

  2. Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30(7):804–14.

    Article  CAS  PubMed  Google Scholar 

  3. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007;47(2):170–80.

    Article  PubMed  Google Scholar 

  4. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, et al. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007;27(7):814–23.

    Article  PubMed  Google Scholar 

  5. Okum MS. Deep-brain stimulation for Parkinson’s disease. New Engl J Med. 2012;367(16):1529–38.

    Article  CAS  Google Scholar 

  6. Peng-Chen Z, et al. Unilateral thalamic deep brain stimulation in essential tremor demonstrates long-term ipsilateral effects. Parkinsonism Relat Disord. 2013;19:1113–7.

    Article  PubMed  Google Scholar 

  7. Pahwa R, et al. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006;104(4):506–12.

    Article  PubMed  Google Scholar 

  8. Vadailhet M, Jutras MF, Grabli D, Roze E. Deep brain stimulation for dystonia. J Neurol Neurosurg Psychiatry. 2013;84(9):1029–42.

    Article  Google Scholar 

  9. Vandewalle V, van der Linden C, Groenewegen J, Caemaert J. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet. 1999;353(9154):724.

    Article  CAS  PubMed  Google Scholar 

  10. Schrock LE, et al. Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Discord. 2014;30(4):448–71.

    Article  Google Scholar 

  11. Leone M, Franzini A, Bussone G. Stereotactic stimulation of posterior hypothalamic gray matter for intractable cluster headache. NEJM. 2001;345(19):1428–9.

    Article  CAS  PubMed  Google Scholar 

  12. Fontaine D, Lazorthes Y, Mertens P, Blond S, Géraud G, Fabre N, et al. Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension. J Headache Pain. 2010;11:23–31.

    Article  CAS  PubMed  Google Scholar 

  13. Walcott BP, Bamber NI, Anderson DE. Successful treatment of chronic paroxysmal hemicrania with posterior hypothalamic stimulation: technical case report. Neurosurgery. 2009;65:E997.

    Article  PubMed  Google Scholar 

  14. Bartsch T, Falk D, Knudsen K. Deep brain stimulation of the posterior hypothalamic area in intractable short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT). Cephalalgia. 2011;31:1405–8.

    Article  CAS  PubMed  Google Scholar 

  15. Lyons MK, Dodick DW, Evidente VG. Responsiveness of short-lasting unilateral neuralgiform headache with conjunctival injection and tearing to hypothalamic deep brain stimulation. J Neurosurg. 2009;110:279–81.

    Article  PubMed  Google Scholar 

  16. Akram H, Miller S, Lagrata S, Hyam J, Jahanshahi M, Hariz M, et al. Ventral tegmental area deep brain stimulation for refractory chronic cluster headache. Neurology. 2016;86(18):1676–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ben-Menachem E, Mañon-Espaillat R, Ristanovic R, Wilder BJ, Stefan H, Mirza W, Tarver WB, Wernicke JF. Vagus nerve stimulation for treatment of partial seizures: a controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia. 1994;35(3):616–26.

    Article  CAS  Google Scholar 

  18. George R, Salinsky M, Kuzniecky R, Rosenfeld W, Bergen D, Tarver WB, Wernicke JF. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia. 1994;35(3):637–43.

    Article  CAS  PubMed  Google Scholar 

  19. Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, Labar DR, Morris GL 3rd, Salinsky MC, Osorio I, Ristanovic RK, Labiner DM, Jones JC, Murphy JV, Ney GC, Wheless JW. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology. 1998;51(1):48–55.

    Article  CAS  Google Scholar 

  20. CM DG, Schachter SC, Handforth A, Salinsky M, Thompson J, Uthman B, Reed R, Collins S, Tecoma E, Morris GL, Vaughn B, Naritoku DK, Henry T, Labar D, Gilmartin R, Labiner D, Osorio I, Ristanovic R, Jones J, Murphy J, Ney G, Wheless J, Lewis P, Heck C. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia. 2000;41(9):1195–200.

    Article  Google Scholar 

  21. Cimpianu CL, Strube W, Falkai P, Palm U, Hasan A. Vagus nerve stimulation in psychiatry: a systematic review of the available evidence. J Neural Transm (Vienna). 2017;124(1):145–58.

    Article  CAS  Google Scholar 

  22. Eljamel S. Vagus nerve stimulation for major depressive episodes. Prog Neurol Surg. 2015;29:53–63.

    PubMed  Google Scholar 

  23. Tronnier VM. Vagus nerve stimulation: surgical technique and complications. Prog Neurol Surg. 2015;29:29–38.

    PubMed  Google Scholar 

  24. Chakravarthy K, Chaudhry H, Williams K, Christo PJ. Review of the uses of vagal nerve stimulation in chronic pain management. Curr Pain Headache Rep. 2015;19(12):54.

    Article  PubMed  Google Scholar 

  25. Ben-Menachem E, Revesz D, Simon BJ, Silberstein S. Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability. Eur J Neurol. 2015;22(9):1260–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Multon S, Schoenen J. Pain control by vagus nerve stimulation: from animal to man...and back. Acta Neurol Belg. 2005;105(2):62–7.

    PubMed  Google Scholar 

  27. Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation. 1999;2:217–22.

    Article  CAS  PubMed  Google Scholar 

  28. Matharu MS, Bartsch T, Ward N, Frackowiak RSJ, Weiner RL, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127:220–30.

    Article  PubMed  Google Scholar 

  29. Popeney CA, Alo KM. Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine. Headache. 2003;43:369–75.

    Article  PubMed  Google Scholar 

  30. Dodick DW, Trentman T, Zimmerman R, Eross EJ. Occipital nerve stimulation for intractable chronic primary headache disorders. Cephalalgia. 2003;23:701.

    Google Scholar 

  31. Schwedt TJ, Dodick DW, Hentz J, Trentman TL, Zimmerman RS. Occipital nerve stimulation for chronic headache—long-term safety and efficacy. Cephalalgia. 2007;27:153–7.

    Article  CAS  PubMed  Google Scholar 

  32. Lipton R, Goadsby P, Cady R, Aurora S, Grosberg B, Freitag F, et al. PRISM study: occipital nerve stimulation for treatment-refractory migraine. Cephalalgia. 2009;29(suppl 1):30.

    Google Scholar 

  33. Joel R, Saper JR, Dodick DW, Silberstein SD, McCarville S, Mark Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31(3):271–85.

    Article  Google Scholar 

  34. Silberstein SD, Dodick DW, Saper J, Huh B, Slavin KV, Sharan A, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012;32(6):1165–79.

    Article  PubMed  Google Scholar 

  35. Dodick DW, Silberstein SD, Reed KL, Deer TR, Slavin KV, Huh B, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2015;35(4):344–58.

    Article  PubMed  Google Scholar 

  36. Magis D, Bruno MA, Fumal A, Gerardy PY, Hustinx R, Laureys S, Schoenen J. Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study. BMC Neurol. 2011;11:25.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Goadsby PJ, Hargreaves R. Refractory migraine and chronic migraine: pathophysiological mechanisms. Headache. 2008;48:799–804.

    Article  PubMed  Google Scholar 

  38. Bartsch T, Goadsby PJ. Anatomy and physiology of pain referral in primary and cervicogenic headache disorders. Headache Curr. 2005;2:42–8.

    Article  Google Scholar 

  39. Reed K, Black S, Banta C, Will K. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia. 2009;30(3):260–71.

    Article  Google Scholar 

  40. Hann S, Sharan A. Dual occipital and supraorbital nerve stimulation for chronic migraine: a single-center experience, review of literature, and surgical considerations. Neurosurg Focus. 2013;35(3):E9.

    Article  PubMed  Google Scholar 

  41. Schoenen J, Vandermissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80:697–704.

    Article  PubMed  Google Scholar 

  42. Schoenen J. Addendum to migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2015;86:2–3.

    Google Scholar 

  43. Magis D, Sava S, d’Elia TS, Baschi R, Schoenen J. Safety and patients’ satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14(1):1.

    Article  Google Scholar 

  44. Brighina F, Palermo A, Fierro B. Cortical inhibition and habituation to evoked potentials: relevance for pathophysiology of migraine. J Headache Pain. 2009;10(2):77–84.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Schoenen J, Wang W, Albert A, Delwaide PJ. Potentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks. Eur J Neurol. 1995;2:115–22.

    Article  CAS  PubMed  Google Scholar 

  46. Schoenen J. Neurophysiological features of the migrainous brain. Neurol Sci. 2006;27(suppl 2):S77–81.

    Article  PubMed  Google Scholar 

  47. Coppola G, Pierelli F, Schoenen J. Habituation and migraine. Neurobiol Learn Mem. 2009;92(2):249–59.

    Article  PubMed  Google Scholar 

  48. de Tommaso M. Laser-evoked potentials in primary headaches and cranial neuralgias. Expert Rev Neurother. 2008;8:1339–45.

    Article  PubMed  Google Scholar 

  49. Brighina F, Piazza A, Vitello G, et al. rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci. 2004;227:67–71.

    Article  PubMed  Google Scholar 

  50. Misra U, Kalita J, Bhoi S. High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study. J Neurol. 2013;260:2793–801.

    Article  PubMed  Google Scholar 

  51. Conforto A, Amaro E, Gonçalves A. Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine. Cephalalgia. 2014;34:464–72.

    Article  PubMed  Google Scholar 

  52. Clark B, Upton A, Kamath M, et al. Transcranial magnetic stimulation for migraine: clinical effects. J Headache Pain. 2006:341–6.

    Google Scholar 

  53. Lipton R, Dodick D, Silberstein S, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomized, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9:373–80.

    Article  PubMed  Google Scholar 

  54. Bhola R, Kinsella E, Giffin N, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute management of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535.

    Article  PubMed  Google Scholar 

  55. Antal A, Kriener N, Lang N, et al. Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia. 2011;31:820–9.

    Article  PubMed  Google Scholar 

  56. Rocha S, Melo L, Boudoux C, et al. Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: a pilot randomized controlled trial. J Neurol Sci. 2015;349:33–9.

    Article  PubMed  Google Scholar 

  57. Dasilva A, Mendonca M, Zaghi S, et al. tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine. Headache. 2012;52:1283–95.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Auvichayapat P, Janyacharoen T, Rotenberg A, et al. Migraine prophylaxis by anodal transcranial direct current stimulation, a randomized, placebo-controlled trial. J Med Assoc Thail. 2012;95:1003–12.

    Google Scholar 

  59. Oshinsky ML, Murphy AL, Hekierski H, Cooper M, Simon BJ. Noninvasive vagus nerve stimulation as treatment for trigeminal allodynia. Pain. 2014;155(5):1037–42.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Mauskop A. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia. 2005;25(2):82–6.

    Article  CAS  PubMed  Google Scholar 

  61. Nesbitt A, Marin J, Tompkins E, Rutteledge M, Goadsby P. Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment. Neurology. 2015;84:5–1.

    Article  CAS  Google Scholar 

  62. Gaul C, Diener HC, Silver N, et al. Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headaches (PREVA): a randomized controlled study. Cephalalgia. 2016;26:534–46.

    Article  Google Scholar 

  63. Goadsby P, Grosberg B, Mauskop A, et al. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia. 2014;34:986–93.

    Article  CAS  PubMed  Google Scholar 

  64. Barbanti P, Grazzi L, Egeo O, et al. Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. J Headache Pain. 2015;16:542.

    Article  Google Scholar 

  65. Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, et al. Chronic migraine headache prevention with noninvasive vagus nerve stimulation: the EVENT study. Neurology. 2016;87(5):529–38.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Murphy JV. Left vagal nerve stimulation in children with medically refractory epilepsy: The Pediatric VNS Study Group. J Pediatr. 1999;134:563–6.

    Article  CAS  PubMed  Google Scholar 

  67. Aaronson ST, Carpenter LL, Conway CR, et al. Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul. 2013;6:631–40.

    Article  PubMed  Google Scholar 

  68. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache neuropeptide changes and effects of acute attacks therapies. Brain. 1994;117(3):427–34.

    Article  PubMed  Google Scholar 

  69. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab. 1999;19(2):115–27.

    Article  CAS  PubMed  Google Scholar 

  70. Kittrelle JP, Grouse DS, Seybold ME. Cluster headache: local anesthetic abortive agents. Arch Neurol. 1985;42(5):496–8.

    Article  CAS  PubMed  Google Scholar 

  71. Robbins L. Intranasal lidocaine for cluster headache. Headache. 1995;35(2):83–4.

    Article  CAS  PubMed  Google Scholar 

  72. Barre F. Cocaine as an abortive agent in cluster headache. Headache. 1982;22(2):69–73.

    Article  CAS  PubMed  Google Scholar 

  73. Costa A, Pucci E, Antonaci F, Sances G, Granella F, Broich G, Nappi G. The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia. 2000;20(2):85–91.

    Article  CAS  PubMed  Google Scholar 

  74. Devoghel JC. Cluster headache and sphenopalatine block. Acta Anaesthesiol Belg. 1981;32:101–7.

    PubMed  CAS  Google Scholar 

  75. Sanders M, Zuurmond WW. Efficacy of sphenopalatine ganglion blockade in 66 patients suffering from cluster headache: a 12- to 70-month follow-up evaluation. J Neurosurg. 1997;87(6):876–80.

    Article  CAS  PubMed  Google Scholar 

  76. Narouze S, Kapural L, Casanova J, Mekhail N. Sphenopalatine ganglion radiofrequency ablation for the management of chronic cluster headache. Headache. 2009;49(4):571–7.

    Article  PubMed  Google Scholar 

  77. Chua NH, Vissers KC, Wilder-Smith OH. Quantitative sensory testing may predict response to sphenopalatine ganglion pulsed radiofrequency treatment in cluster headaches: a case series. Pain Pract. 2011;11(5):439–45.

    Article  PubMed  Google Scholar 

  78. Van Bets B, Raets I, Gypen E, Mestrum R, Heylen R, Van Zundert J. Pulsed radiofrequency treatment of the pterygopalatine (sphenopalatine) ganglion in cluster headache: a 10 year retrospective analysis: 14AP7-5. Eur J Anaesthesiol. 2014;31:233.

    Article  Google Scholar 

  79. Fang L, Jingjing L, Ying S, Lan M, Tao W, Nan J. Computerized tomography-guided sphenopalatine ganglion pulsed radiofrequency treatment in 16 patients with refractory cluster headaches: twelve- to 30-month follow-up evaluations. Cephalalgia. 2016;36(2):106–12.

    Article  PubMed  Google Scholar 

  80. Loomba V, Upadhyay A, Kaveeshvar H. Radiofrequency ablation of the sphenopalatine ganglion using cone beam computed tomography for intractable cluster headache. Pain Physician. 2016;19:E1093–6.

    PubMed  Google Scholar 

  81. Kudrow L, Kudrow DB, Sandweiss JH. Rapid and sustained relief of migraine attacks with intranasal lidocaine: preliminary findings. Headache. 1995;35(2):79–82.

    Article  CAS  PubMed  Google Scholar 

  82. Maizels M, Scott B, Cohen W, Chen W. Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. JAMA. 1996;276(4):319–21.

    Article  CAS  PubMed  Google Scholar 

  83. Maizels M, Geiger AM. Intranasal lidocaine for migraine: a randomized trial and open-label follow-up. Headache. 1999;39(8):543–51.

    Article  CAS  PubMed  Google Scholar 

  84. Cady R, Saper J, Dexter K, Manley HR. A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with Tx360® as acute treatment for chronic migraine. Headache. 2015;55(1):101–16.

    Article  PubMed  Google Scholar 

  85. Tepper SJ, Rezai A, Narouze S, Steiner C, Mohajer P, Ansarinia M. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache. 2009;49(7):983–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology, Medical College of Wisconsin, Milwaukee, WI, USA

    Derrick Alan Shumate & Frederick G. Freitag

Authors
  1. Derrick Alan Shumate
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frederick G. Freitag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frederick G. Freitag .

Editor information

Editors and Affiliations

  1. Department of Headache and Pain Medicine, Icahn School of Medicine at Mt. Sinai, Department of Headache and Pain Medicine, New York, NY, USA

    Mark W. Green

  2. Neurology & Neurological Sciences, Stanford School of Medicine Neurology & Neurological Sciences, Stanford, CA, USA

    Robert Cowan

  3. Department of Neurology, Medical College of Wisconsin, Department of Neurology, Milwaukee, WI, USA

    Frederick G. Freitag

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shumate, D.A., Freitag, F.G. (2019). Neurostimulation in the Management of Chronic Migraine. In: Green, M., Cowan, R., Freitag, F. (eds) Chronic Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-91491-6_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91491-6_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-91490-9

  • Online ISBN: 978-3-319-91491-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation